Sorry, you need to enable JavaScript to visit this website.

FDA approves Removal of Boxed Warning Regarding Serious Neuropsychiatric Events from Chantix (Varenicline) labeling.

January 30, 2017
Labeling revisions: removal of the Boxed warning from Chantix USPI. Please see the full press release via the link below for further details.